Philips Sees Hit From Product Safety Fault

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-04-26 HKT 14:36

Share this story

facebook

  • Philips says it's looking for means to mitigate a possible safety risk in some sleep and respiratory care products File photo: AFP

    Philips says it's looking for means to mitigate a possible safety risk in some sleep and respiratory care products File photo: AFP

Dutch firm Philips said on Monday it anticipates a hit of up to 250 million euros (US$302 million) from a possible safety risk in some sleep and respiratory care products, even as first quarter profits edged higher.

The company, which has diversified into healthcare and last month sold off its domestic appliance business, said net profit was 40 million euros in the three months to March 31, a 2.6-percent rise on a year earlier.

Philips had sales of 3.8 billion euros in the first quarter, up 3.6 percent from the same period last year.

"Regretfully, we have identified a quality issue in a component that is used in certain sleep and respiratory care products, and are initiating all precautionary actions to address this issue, for which we have taken a 250 million euro provision," Philips CEO Frans van Houten said in a statement.

Philips said there were "possible risks to users" from sound-dampening foam in some sleep and respiratory care devices, which could degrade under conditions including unapproved cleaning methods, plus high humidity and temperature.

The firm said it was talking to regulators about the problem, which mainly affects first generation DreamStation products, and "initiating appropriate actions to mitigate these possible risks."

Amsterdam-based Philips started off as a lighting company more than 100 years ago but has undergone major changes in recent years, focusing in particular on remote healthcare.

Philips announced in March that it was selling its home appliance business to Asian investment firm Hillhouse Capital for 3.7 billion euros, and sales from this were now listed under discontinued operations, Monday's results statement said.

The firm said that despite continued "uncertainty" related to the Covid-19 pandemic it had upgraded its sales forecast for 2021on the back of increased demand for its healthcare products. (AFP)

RECENT NEWS

US Stocks Rise On Hopes Of Pause In Rate Increases

Wall Street stocks finished solidly higher on Thursday, reflecting better sentiment on the US economy and a consensus vi... Read more

China's Financial Risks 'controllable': Regulators

The head of the National Financial Regulatory Administration on Thursday told a high-profile forum in Shanghai that the ... Read more

Banks Cut Yuan Deposit Rates, Could Boost Consumption

China's biggest banks on Thursday said they have lowered interest rates on yuan deposits, in actions that could ease pre... Read more

Cheese And Wine Put EU, Australia Deal In Peril

Australia on Thursday threatened to walk away from a blockbuster free trade deal with the European Union unless its prod... Read more

US Stocks End Mixed As Tech Shares Are Sold Off

Gains by industrial companies lifted the Dow on Wednesday, while weakness among technology shares pushed the Nasdaq deci... Read more

Amazon 'plans Prime Video Streaming Service With Ads'

Amazon.com is planning to launch an advertising-supported tier of its Prime Video streaming service, the Wall Street Jou... Read more